TY - JOUR
T1 - factors predicting bone mineral density (BMD) changes in young women over a One-Year study
T2 - Changes in body weight and bone metabolic markers during the menstrual cycle and their effects on BMD
AU - Iida, Tadayuki
AU - Chikamur, Chiho
AU - Ishikawa, Hiroaki
AU - Aoirf, Satomi
AU - Ikeda, Hiromi
AU - Haradae, Toshihide
AU - Katada, Kazuhiro
AU - Ishizaki, Fumiko
AU - Yatsuya, Hiroshi
AU - Ono, Yuichiro
PY - 2012/10/25
Y1 - 2012/10/25
N2 - Currently, 26% of Japanese women in their twenties are under weight, and therefore at risk of developing various metabolic abnormalities due to an inadequate nutrient intake, which in turn affects the acquisition of a peak bone mineral density (BMD). In this study, we aimed to clarify the effects of menstrual cycle-related changes in body weight and bone metabolic marker levels on the BMD changes. The subjects were 42 women (19.6 ± 0.8 years). The levels of osteocalcin (OC), BAP, s-NTx, u-DPD, and E2 in the menstrual and ovulatory phases were measured. The associations between dependent variables (BMD changes/year in the lumbar spine, femur, femoral neck) and explanatory variables (body weight changes/year, the levels of OC, BAP, s-NTx, u-DPD) were evaluated using multiple regression analysis. Analysis of the correlations between the changes in bone metabolic markers and changes in BMD showed a correlation between the OC level in the menstrual phase and changes in the BMD of the entire femur, suggesting that a high OC level protects against BMD reduction, probably by promoting osteoblast activity, and that bone formation activity suppresses the decrease in BMD. These results suggest that, to predict BMD changes from bone metabolic markers in young women, it is necessary to measure OC levels in the menstrual phase.
AB - Currently, 26% of Japanese women in their twenties are under weight, and therefore at risk of developing various metabolic abnormalities due to an inadequate nutrient intake, which in turn affects the acquisition of a peak bone mineral density (BMD). In this study, we aimed to clarify the effects of menstrual cycle-related changes in body weight and bone metabolic marker levels on the BMD changes. The subjects were 42 women (19.6 ± 0.8 years). The levels of osteocalcin (OC), BAP, s-NTx, u-DPD, and E2 in the menstrual and ovulatory phases were measured. The associations between dependent variables (BMD changes/year in the lumbar spine, femur, femoral neck) and explanatory variables (body weight changes/year, the levels of OC, BAP, s-NTx, u-DPD) were evaluated using multiple regression analysis. Analysis of the correlations between the changes in bone metabolic markers and changes in BMD showed a correlation between the OC level in the menstrual phase and changes in the BMD of the entire femur, suggesting that a high OC level protects against BMD reduction, probably by promoting osteoblast activity, and that bone formation activity suppresses the decrease in BMD. These results suggest that, to predict BMD changes from bone metabolic markers in young women, it is necessary to measure OC levels in the menstrual phase.
UR - http://www.scopus.com/inward/record.url?scp=84867662813&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84867662813&partnerID=8YFLogxK
M3 - Article
C2 - 22918203
AN - SCOPUS:84867662813
SN - 0386-300X
VL - 66
SP - 307
EP - 315
JO - Acta Medica Okayama
JF - Acta Medica Okayama
IS - 4
ER -